Calls upon all entities in the insulin supply chain to ensure that no person with diabetes is denied affordable access to insulin; and Calls upon Congress to hold hearings with all entities in the insulin supply chain to identify the reasons for the dramatic increases in insulin prices and to take action to ensure that all people who use insulin have affordable access to the insulin they need.